Hermann R Bohnenkamp

Summary

Affiliation: MediGene AG
Country: Germany

Publications

  1. ncbi Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses
    Hermann R Bohnenkamp
    Cancer Research UK, Breast Cancer Biology Group, Thomas Guy House, 3rd Floor, Guy s Hospital, London SE1 9RT, UK
    Cell Immunol 247:72-84. 2007
  2. doi T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients
    Julia A Coleman
    King s College London, Research Oncology, Breast Cancer Biology Group, Bermondsey Wing, Guy s Hospital, Great Maze Pond, London, United Kingdom
    Int J Cancer 128:2114-24. 2011
  3. pmc Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
    Matthew J Grimshaw
    Breast Cancer Biology Group, King s College London School of Medicine, Guy s Hospital Campus, Great Maze Pond, London, UK
    Breast Cancer Res 10:R52. 2008
  4. ncbi Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers
    Hermann R Bohnenkamp
    Institute of Biotechnology 2, Research Center Jülich GmbH, Leo Brandt Strasse 1, 52428 Jülich, Germany
    Cell Immunol 231:112-25. 2004
  5. ncbi Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells
    Hermann R Bohnenkamp
    Institute of Biotechnology 2, Research Center Jülich GmbH, Leo Brandt Strasse 1, 52428 Jülich, Germany
    J Immunol Methods 294:67-80. 2004

Collaborators

Detail Information

Publications5

  1. ncbi Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses
    Hermann R Bohnenkamp
    Cancer Research UK, Breast Cancer Biology Group, Thomas Guy House, 3rd Floor, Guy s Hospital, London SE1 9RT, UK
    Cell Immunol 247:72-84. 2007
    ..The results indicate that dendritic cells process, combine and integrate signals delivered by pathogens to launch effective adaptive immune responses...
  2. doi T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients
    Julia A Coleman
    King s College London, Research Oncology, Breast Cancer Biology Group, Bermondsey Wing, Guy s Hospital, Great Maze Pond, London, United Kingdom
    Int J Cancer 128:2114-24. 2011
    ..One of these, peptide 73 (QLYALPCVL), was analyzed for memory phenotype, and found to have a significantly higher proportion of central memory T cells than the control group, demonstrating a previous exposure to the peptide...
  3. pmc Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
    Matthew J Grimshaw
    Breast Cancer Biology Group, King s College London School of Medicine, Guy s Hospital Campus, Great Maze Pond, London, UK
    Breast Cancer Res 10:R52. 2008
    ....
  4. ncbi Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers
    Hermann R Bohnenkamp
    Institute of Biotechnology 2, Research Center Jülich GmbH, Leo Brandt Strasse 1, 52428 Jülich, Germany
    Cell Immunol 231:112-25. 2004
    ..These results provide evidence for a strong T(H)1 polarization and cross-priming of MUC1-specific CD8+ T cells and demonstrate the feasibility of using lysate-pulsed dendritic cells in breast cancer immunotherapy...
  5. ncbi Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells
    Hermann R Bohnenkamp
    Institute of Biotechnology 2, Research Center Jülich GmbH, Leo Brandt Strasse 1, 52428 Jülich, Germany
    J Immunol Methods 294:67-80. 2004
    ..These results indicate that the yield of dendritic cells is mainly influenced by the percentage of apoptotic cells in the inoculum, and this has implications for DC generation in clinical applications...